RHYTHM PHARMACEUTICALS, INC. short interest in 2022
In 2022, RHYTHM PHARMACEUTICALS, INC.'s disclosed short interest ran from 7.83% of shares outstanding on 14 Jan 2022 to 13.91% on 30 Dec 2022, a change of +6.08 percentage points. The year's high was 16.55% on 31 Oct 2022 and its low 6.15% on 13 May 2022, averaging 10.67% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.69 days on 30 Nov 2022. Full history: RHYTHM PHARMACEUTICALS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 7.83% (14 Jan 2022)
- End of year
- 13.91% (30 Dec 2022)
- Change
- +6.08 pp
- High
- 16.55% (31 Oct 2022)
- Low
- 6.15% (13 May 2022)
- Average
- 10.67%
- Highest days to cover
- 15.69 (30 Nov 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 7.83% | 12.27 | |
| 31 Jan 2022 | 8.24% | 11.85 | |
| 15 Feb 2022 | 8.70% | 6.97 | |
| 28 Feb 2022 | 9.06% | 4.64 | |
| 15 Mar 2022 | 9.60% | 10.13 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 7.46% | 5.20 | |
| 14 Apr 2022 | 7.34% | 10.06 | |
| 29 Apr 2022 | 6.79% | 14.07 | |
| 13 May 2022 | 6.15% | 4.89 | 10-Q filed, results (8-K) |
| 31 May 2022 | 7.13% | 6.92 | |
| 15 Jun 2022 | 7.28% | 5.12 | |
| 30 Jun 2022 | 6.29% | 1.06 | |
| 15 Jul 2022 | 11.80% | 1.18 | |
| 29 Jul 2022 | 14.27% | 1.85 | |
| 15 Aug 2022 | 11.04% | 2.91 | results (8-K), 10-Q filed |
| 31 Aug 2022 | 11.45% | 6.84 | |
| 15 Sep 2022 | 11.89% | 3.37 | |
| 30 Sep 2022 | 15.05% | 4.46 | |
| 14 Oct 2022 | 15.02% | 9.19 | |
| 31 Oct 2022 | 16.55% | 13.94 | |
| 15 Nov 2022 | 14.98% | 10.67 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 13.96% | 15.69 | |
| 15 Dec 2022 | 14.35% | 13.07 | |
| 30 Dec 2022 | 13.91% | 13.95 |
See also: RHYTHM PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.